Inventors:
Ines Barroso - Cambridge, GB
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Julie Blake - San Francisco CA, US
Mark Borowsky - Needham MA, US
Neil Burford - Durham CT, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton, CA
Kimberly Gietzen - San Jose CA, US
Ann Gorvad - Bellingham WA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Francisco CA, US
Craig Ison - San Jose CA, US
Farrah Khan - Canton MI, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Sally Lee - San Jose CA, US
Soo Lee - Mountain View CA, US
Joana Li - Millbrae CA, US
Dyung Lu - San Jose CA, US
Yan Lu - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
William Sprague - Sacramento CA, US
Y Tang - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Michael Thornton - Oakland CA, US
Uyen Tran - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Huibin Yue - Cupertino CA, US
Yeganeh Zebarjadian - San Francisco CA, US
International Classification:
C12Q001/68
C07H021/04
C12N009/22
US Classification:
435006000, 435069100, 435199000, 435320100, 435325000, 536023200
Abstract:
Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
